Medrysone
Back to searchMolecule Structure
Scientific Name
Medrysone
Description of the Drug
Medrysone is a topical glucocorticoid applied ophthalmically for the treatment of various ocular inflammatory or allergic conditions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00253
http://www.drugbank.ca/drugs/DB00253
Brand Name(s)
Not Available
Company Owner(s)
Allergan Pharmaceutical
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4493 |
| PharmGKB | PA450346 |
| Human Metabolome Database | HMDB0014398 |
| DrugBank | DB00253 |
| PubChem: Thomson Pharma | 14827409 |
| PubChem | 247839 |
| LINCS | LSM-3259 |
| Nikkaji | J7.644I |
| EPA CompTox Dashboard | DTXSID6045371 |
| DrugCentral | 1662 |
| Guide to Pharmacology | 7086 |
| rxnorm | MEDRYSONE |
| KEGG Ligand | C14643 |
| ChEBI | 34829 |
| ZINC | ZINC000003977945 |
